The most commonly CDH16 positive cancers included renal cell carcinomas, nephrogenic adenomas, and follicular neoplasms of the thyroid, followed by tumors of the female genital tract and various categories of neuroendocrine tumors. Here, CDH16 is linked to neoplasm.